Xu Xianxiang, Lin Lin, Ning Wenjie, Zhou Xinyi, Ullah Aftab, Yang Huiyong, Wu Xunxun, Diao Yong
School of Medicine, Huaqiao University, 269 Chenghua North Road, Quanzhou 362021, China.
Pharmaceutics. 2025 May 20;17(5):674. doi: 10.3390/pharmaceutics17050674.
: Indigo naturalis (IN) is a traditional Chinese medicine concocted from medicinal plants such as (Nees) Bremek. IN has multifaceted pharmacological activities. Recent research highlights the remarkable efficacy of IN in treating ulcerative colitis (UC). This study investigates the efficacy of Indigo Naturalis prepared using a novel method (NIN) in ameliorating UC. : We have developed a new IN processing technology without the use of lime. Correspondingly, the content of active ingredients has relatively increased in NIN. In this study, dextran sulfate sodium salt (DSS) induced UC models among male KM mice, and the protective effects of NIN on UC were verified. : NIN could significantly improve weight loss, diarrhea and prolapse, bloody stools, elevated Disease Activity Index (DAI) and alleviate the colitis symptoms of mice; it could also improve the shortening of colon, disappearance of intestinal crypts, epithelial cell destruction and inflammatory infiltration caused by UC; and it could also significantly reduce the Histological Index (HI). In addition, NIN relieved the inflammatory response by decreasing the content of pro-inflammatory cytokines TNF-α and IL-1β and elevating the content of anti-inflammatory cytokines IL-10 and IL-22. It also restored the intestinal mucosal barrier by increasing the level of MUC2 protein expression at the site of colonic injury. : The significant effects of NIN on UC were verified for the first time, suggesting that NIN was worth further developing into a novel therapeutic drug and, necessarily, further safety evaluations and comparisons with traditional IN will help in the application of NIN.
青黛是一种由马蓝等药用植物炮制而成的传统中药。青黛具有多方面的药理活性。近期研究突出了青黛在治疗溃疡性结肠炎(UC)方面的显著疗效。本研究调查了采用新方法制备的青黛(NIN)改善UC的疗效。我们开发了一种不使用石灰的青黛加工新技术。相应地,NIN中活性成分的含量相对增加。在本研究中,用葡聚糖硫酸钠(DSS)诱导雄性KM小鼠建立UC模型,并验证了NIN对UC的保护作用。NIN可显著改善小鼠体重减轻、腹泻、脱肛、便血、疾病活动指数(DAI)升高的情况,并减轻结肠炎症状;还可改善UC所致的结肠缩短、肠隐窝消失、上皮细胞破坏和炎症浸润;还可显著降低组织学指数(HI)。此外,NIN通过降低促炎细胞因子TNF-α和IL-1β的含量以及提高抗炎细胞因子IL-10和IL-22的含量来减轻炎症反应。它还通过增加结肠损伤部位MUC2蛋白表达水平来恢复肠道黏膜屏障。首次验证了NIN对UC有显著作用,表明NIN值得进一步开发成一种新型治疗药物,并且,必要的进一步安全性评估以及与传统青黛的比较将有助于NIN的应用。